Predicting employment status and subjective quality of life in patients with schizophrenia  by Fujino, Haruo et al.
Schizophrenia Research: Cognition 3 (2016) 20–25
Contents lists available at ScienceDirect
Schizophrenia Research: Cognition
j ourna l homepage: ht tp : / /www.sch iz rescogn i t ion.com/Predicting employment status and subjective quality of life in patients
with schizophreniaHaruo Fujino a, Chika Sumiyoshi b, Tomiki Sumiyoshi c, Yuka Yasuda d, Hidenaga Yamamori d, Kazutaka Ohi d,
Michiko Fujimoto d, Ryota Hashimoto d,e,⁎, Masatoshi Takeda d,e, Osamu Imura a
a Graduate School of Human Sciences, Osaka University, 1-2 Yamadaoka, Suita, Osaka 565-0871, Japan
b Faculty of Human Development and Culture, Fukushima University, 1 Kanayagawa, Fukushima, Fukushima 960-1296, Japan
c Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashimachi, Kodaira, Tokyo 187-8551, Japan
d Department of Psychiatry, Osaka University Graduate School of Medicine, D3, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan
e Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, D3, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan
a b s t r a c ta r t i c l e i n f o⁎ Corresponding author. Tel./fax: +81 668793074.
E-mail address: hashimor@psy.med.osaka-u.ac.jp (R.
http://dx.doi.org/10.1016/j.scog.2015.10.005
2215-0013/© 2016 The Authors. Published by Elsevier InArticle history:
Received 26 August 2015
Received in revised form 9 October 2015
Accepted 15 October 2015






EmploymentAlthough impaired social functioning, particularly poor employment status, is a cardinal feature of patients
with schizophrenia and leads to decreased quality of life (QOL), few studies have addressed the relationship
between these two clinical issues. The aim of this study was to determine whether employment status
predicts subjective QOL and to evaluate a model in which functional capacity mediates the relationship
between general cognitive performance and employment status. Ninety-three patients with schizophrenia
were administered a comprehensive battery of cognitive tests, the UCSD Performance-based Skills
Assessment-Brief version (UPSA-B), the Social Functioning Scale (SFS), and the Subjective Quality of Life
Scale (SQLS). First, we evaluated a model for predicting the employment/occupation subscale score of the SFS
using path analysis, and the model ﬁtted well (χ2 (4) = 3.6, p = 0.46; CFI = 1.0; RMSEA b 0.001, with 90%
CIs: 0–0.152). Employment status was predicted by negative symptoms and functional capacity, which was in
turn predicted by general cognitive performance. Second, we added subjective QOL to this model. In a ﬁnal
path model, QOL was predicted by negative symptoms and employment status. This model also satisﬁed good
ﬁt criteria (χ2 (7) = 10.3, p = 0.17; CFI = 0.987; RMSEA = 0.072, with 90% CIs: 0–0.159). The UPSA-B and
SFS scores were moderately correlated with most measures of cognitive performance. These results support
the notion that better employment status enhances subjective QOL in patients with schizophrenia.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The impairment of functional outcomes is a core problem in
schizophrenia and may worsen subjective and objective quality of life
(QOL) for patients. Speciﬁcally, subjective QOL is an important
patient-reported outcome, reﬂecting individuals' perceptions of
psychological wellness and satisfaction (Karow et al., 2014).
Functional outcome is evaluated by some related, but clinically
distinct, manifestations such as cognitive function, functional capac-
ity/skills, and social functioning (Green et al., 2000; Green et al.,
2004). Cognitive abilities are measured using standardized neuropsy-
chological tests in a laboratory setting. The assessment of functional
capacity/skill is associated with an individual's ability to manage his
or her everyday activities. Accordingly, performance based measures,
such as the UCSD Performance-based Skills Assessment (UPSA) and its
brief version, the UPSA-B (Mausbach et al., 2007), have been
developed to evaluate the ability to perform daily activities, including
counting money, making calls, and managing medical appointmentsHashimoto).
c. This is an open access article und(Mausbach et al., 2007; Patterson et al., 2001). Social functioning
generally means functioning in the real world, such as independent
living, interpersonal relationships, and work (Harvey et al., 2011;
Leifker et al., 2011). Employment status has been considered as a
particularly important functional outcome of individuals with
schizophrenia (Nuechterlein et al., 2011).
Reducing psychiatric symptoms, particularly negative symptoms,
is also considered to improve QOL, thus enhancing therapeutic
alliance and treatment satisfaction (Karow et al., 2012a). Although
negative symptoms have been shown to affect QOL in patients with
schizophrenia (Brissos et al., 2011;Woon et al., 2010), only a minority
of patients exhibit substantial improvement in QOL, even after
achieving symptom remission (Karadayi et al., 2011; Schennach-
Wolff et al., 2009). QOL has also been associated with functional
outcomes, including employment status, independent living, engage-
ment in daily activities, and maintaining personal relationships
(Galuppi et al., 2010; Karadayi et al., 2011). In sum, cognitive function
and psychiatric symptoms are considered to play a major role in social
functioning in patients with schizophrenia (Bowie et al., 2008).
General cognitive function is assessed by performance on neuropsy-
chological tests ofmost cognitive domains (Dickinson et al., 2004) andhaser the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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However, a conceptual model of the link between cognitive function and
social functioning suggests a discrepancy between cognitive performance
in the laboratory setting and community outcomes (Bowie and Harvey,
2006; Green et al., 2004). Therefore, it is reasonable to assume that
functional abilities/capacity, as evaluated by co-primary measures (e.g.,
UPSA-B), mediates cognitive function and social functioning (Bowie et al.,
2006; Green et al., 2012). Previous studies have shown a role of functional
capacity as a mediator of cognitive dysfunctions on employment status
(Bowie et al., 2006; Bowie et al., 2010).
Although statistical modeling has been employed to examine the
relationships among cognitive function, functional abilities, and social
functioning (interpersonal skills, community activities, and work
skills) (Bowie et al., 2006), there is little information on specifying a
model to include pathways to QOL (Hwang et al., 2009; Savilla et al.,
2008). We seek to extend understandings on pathways to QOL by
developing a comprehensive model of the relationships among
cognitive function, functional capacity, employment status, psychiat-
ric symptoms, and QOL.
The purpose of this study was to determine clinical predictors of
social functioning and QOL in Japanese patients with schizophrenia.
We focused on employment status as one of the most important
aspects of social functioning. We hypothesized that the effect of
cognitive performance on employment status would be mediated by




A total of 93 patients with schizophrenia (53 male, 40 female)
participated in this study. Patients were outpatients treated at the
Department of Psychiatry of Osaka University Hospital. A consensus
diagnosis, according to Diagnostic and Statistical Manual of Mental
Disorders-IV (DSM-IV) criteria, was made by experienced senior
psychiatrists using the Structured Clinical Interview for DSM-IV
(SCID) for schizophrenia (American Psychiatric Association, 1994).
Psychotic symptoms (positive symptoms, negative symptoms, and
general psychopathology) were evaluated using the Positive and
Negative Syndrome Scale (PANSS) (Kay et al., 1987).
All participants provided written informed consent after the study
procedures were fully explained. All procedures were conducted
according to the Declaration of Helsinki and approved by the ethics
committee of Osaka University.
2.2. Assessment of cognitive performance
Cognitive performance was assessed using a comprehensive
neuropsychological battery, which has been employed in previous
studies (Dickinson et al., 2014; Ohi et al., 2015). This included the
following cognitive domains: verbal memory, n-back/controlled
attention, visual memory, processing speed, card sorting/reasoning,
and span/working memory. The following neuropsychological tests
were used: the Japanese Adult Reading Test (JART) (Hashimoto et al.,
2013; Matsuoka et al., 2006); the Wechsler Adult Intelligence Scale,
Third Edition (WAIS-III) Similarities, Digit Span, Arithmetic, Picture
Completion, and Digit Symbol Coding subtests (Japanese WAIS-III
Publication Committee, 2006; Wechsler, 1997); the Wechsler Mem-
ory Scale-Revised (WMS-R) Logical Memory 1, Logical Memory 2,
Verbal Paired Association, Visual Paired Association 1, and Visual
Paired Association 2 tests (Sugishita, 2001; Wecheler, 1987); the
Continuous Performance Test (CPT, 2–4 digits); the Wisconsin Card
Sorting Test (WCST) categories achieved and number of total errors;the Rey Auditory Verbal Learning Tests (AVLT) total recalls (I–V
trials); Category Fluency; and Letter Fluency. A general cognitive
composite (g), was calculated in the same manner, as described in
previous studies (Dickinson et al., 2011; Dickinson et al., 2014; Ohi
et al., 2015). Scores on different measures were converted to z-scores
using control means and standard deviations (data not shown). Then,
g composites were derived from the mean of the z-scores of the
cognitive measures.
2.3. Assessment of functional capacity and social functioning
We assessed functional capacity with the UCSD Performance-
based Skills Assessment-brief (UPSA-B) (Mausbach et al., 2007). The
UPSA-B was developed as an abbreviated version of the UPSA that
assesses daily living skills based on role-play performance among
patients with mental illnesses (Patterson et al., 2001). The UPSA-B
requires a shorter administration time and contains two of the ﬁve
subdomains of the full version. It measures everyday functional skills
of patients using role-play tasks for ﬁnance (e.g., counting money and
reading a bill) and communication (e.g., dialing a number from
memory and calling to reschedule a doctor's appointment) (Mausbach
et al., 2007; Sumiyoshi et al., 2014).Higher scores indicate greater ability
in every-day activities (scores range from 0–100).
Social functioning was assessed using the SFS part included in the
modiﬁed Social Functioning Scale/Social Adaptation Scale (modiﬁed
SFS/SAS). The modiﬁed SFS/SAS was created in the MATRICS
Psychometric and Standardization Studies (MATRICS-PASS; Green
et al., 2008;Kernet al., 2008;Nuechterlein et al., 2008) for theMATRICS
Consensus Cognitive Battery. The Japanese version of the modiﬁed
SFS/SAS was produced by Sumiyoshi and Sumiyoshi (2011), and its
utility was recently reported (Sumiyoshi et al., 2015). The SFS part
was administered as a self-report questionnaire. Individuals were
asked to rate their actual level of activity and ability in areas of social
function. Investigators (clinical psychologists or trained research
assistants) also reviewed these ratings to conﬁrm the validity of the
report. The SFS consists of seven subscales: social engagement,
interpersonal communication, independence-performance, independence-
competence, recreation, pro-social, and employment/occupation.
The SFS total scores were derived from the sum of these subscale
scores. Higher scores indicate better real-world functioning in the
community. The SFS and the Japanese version were originally
developed by Birchwood et al. (1990), and Nemoto et al. (2008),
respectively.
2.4. Assessment of subjective QOL
Subjective QOL was evaluated using the Schizophrenia Quality of
Life Scale (SQLS). The SQLS is a self-report questionnaire, which
provides scores on three subscales: dysfunction of psycho-social
activity, dysfunction of motivation/energy, and level of symptoms/
side effects (Wilkinson et al., 2000). Lower scores indicate better QOL.
The SQLS has been shown to be reliable, valid, and practical in patients
with schizophrenia (Kaneda et al., 2002).
2.5. Statistical analyses
We applied path analysis to evaluate path models. The PANSS
positive and negative symptoms subscale scores, g composite score
(general cognitive performance), the UPSA-B total score, and
employment/occupation subscale of the SFS, and SQLS were included
in the path models. These models were developed through an
iterative procedure applied in a previous study (Bowie et al., 2006).
The non-signiﬁcant paths with the smallest contribution to the
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model until the best-ﬁtting model was identiﬁed.
We employed χ2 statistics, a comparative ﬁt index (CFI), and root
mean-square error of approximation (RMSEA) with 90% conﬁdence
intervals (CIs) to evaluate model ﬁt, as recommended in the literature
(Jackson et al., 2009). A good-ﬁtting model was determined by
non-signiﬁcant χ2 tests, CFI greater than 0.95, and RMSEA less than
0.08. Pearson's correlation coefﬁcients were calculated to examine the
relationships among subdomains of cognitive function, functional
capacity, social functioning, psychiatric symptoms, and QOL. Statisti-
cal analyses were performed using SPSS and AMOS 22.0 software
(SPSS Japan Inc., Tokyo, Japan).3. Results
3.1. Analyses of the employment/occupation model
First, we evaluated a model predicting employment status
(employment/occupation model), which is a modiﬁed version of
work skill prediction model of Bowie et al. (2006). In the model, the
employment/occupation domain of the SFS was used as the outcome
variable. Positive and negative symptoms and the g composite were
included as independent variables. The UPSA-B total score was
included as a mediating variable inﬂuencing the effect of the g
composite on employment/occupation. Thismodel provided a good ﬁt
based on a non-signiﬁcant χ2 test (χ2 = 3.6, df = 4, p = 0.46) and
ﬁt indices (CFI = 1.0; RMSEA b 0.001, with 90% CIs: 0–0.152) (Fig. 1).
The employment/occupation model adequately satisﬁed ﬁt criteria,
suggesting that functional capacity mediated the relationship
between the g composite and employment. The employment/
occupation domain of the SFS was predicted by negative symptoms
(β = 0.38, p b 0.001) and functional capacity (β = 0.33, p b 0.001),
explaining 33% of the variance. Positive symptoms did not inﬂuence
employment status. Positive and negative symptoms were both
moderately related to g (p b 0.01). Additionally, we also tested a
model using the SFS total score instead of the employment/
occupation score. Generally, ﬁt indices indicated a good ﬁt of the
model for patients (χ2 = 6.6, df = 4, p = 0.16, CFI = 0.988) with
the exception of the RMSEA, which was slightly larger than the
threshold criterion for good ﬁt (RMSEA = 0.085, with 90% CIs:
0–0.196). Other models that included the remaining domains of the
SFS failed to satisfy good ﬁt criteria or did not show a signiﬁcant effect
of the UPSA-B on the SFS domains (p N 0.05).Fig. 1. Employment/occupation model predicting employment status in patients with
schizophrenia. The employment/occupation model showed good ﬁt based on ﬁt indices
(χ2 = 3.6, df = 4, p = 0.46; CFI = 1.0; RMSEA b 0.001, with 90% CIs: 0–0.152).3.2. Analyses of the QOL model
We further evaluated a model in which the subjective QOL was
added to the employment/occupation model (QOL model) as a
higher-order outcome variable. Because two SQLS subscales, psycho-
social and symptoms/side effects, were not predicted by employment
status (β = −0.087, p = 0.42; β = –0.088, p = 0.42), they were not
included in the QOL model. The motivation/energy subscale ﬁt the
QOL model (χ 2 = 10.3, df = 7, p = 0.17; CFI = 0.987;
RMSEA = 0.072, with 90% CIs: 0–0.159) (Fig. 2). The SQLS motiva-
tion/energy score was predicted by negative symptoms and employ-
ment status (β = 0.42, p b 0.001; β = –0.21, p = 0.03), explaining
31% of the variance in SQLS motivation/energy.
3.3. Correlations among social capacity, social functioning, and other
variables
Demographic data, clinical information, and other variables are
summarized in Table 1. Correlations between functional capacity,
social functioning, cognitive performance, clinical variables, and QOL
are presented in Table 2. The UPSA-B scores were correlated with all
cognitive measures and psychiatric symptoms. Generally,
correlation coefﬁcients between cognitive performance and the
UPSA-B (r = 0.3–0.7) were slightly higher than the corresponding
coefﬁcients for the SFS (r = 0.2–0.4).
4. Discussion
The purpose of this study was to determine the predictors of
employment status and subjective QOL and to evaluate the hypoth-
esized model of these relationships for Japanese patients with
schizophrenia. To the best of our knowledge, this is the ﬁrst attempt
to construct a comprehensive model including cognitive function,
functional capacity, employment status, psychiatric symptoms, and
QOL, to investigate complex relationships of the variables using
path-modeling approach. Our results support the meditational role of
functional capacity in the relationship between cognitive perfor-
mance and employment status, which leads to better QOL.
The employment/occupation model met the criteria for a good ﬁt,
whereas the othermodel predicting overall social functioning showed
slightly larger RMSEA than those required for good ﬁt criteria. The
former model successfully explained variables in a manner consistentFig. 2. Quality of life (QOL) model predicting subjective QOL in patients with
schizophrenia. The lower scores indicate better QOL in motivation/energy subscale of
the Schizophrenia Quality of Life Scale (SQLS). The QOLmodel showed good ﬁt based on
ﬁt indices (χ2 = 10.3, df = 7, p = 0.17; CFI = 0.987; RMSEA = 0.072, with 90% CIs:
0–0.159).
Table 1
Demographic and clinical characteristics, cognitive performance, functional skills, and
social functioning of patients.
Mean (SD)
Demographics Sex (male/female) (n) 53/40
Age 34.1 (12.0)
Education (years) 13.8 (2.2)
Age at onset 23.9 (10.1)
Duration of illness (years) 10.3 (7.7)
Cognitive performance JART 103.3 (9.6)
WAIS Similarities 8.9 (3.3)
WAIS Digit Span 9.4 (3.6)
WAIS Arithmetic 8.4 (3.5)
WAIS Picture Completion 8.3 (3.8)
WAIS Digit Symbol Coding 6.9 (3.4)
WMS Logical Memory 1 18.4 (10.4)
WMS Logical Memory 2 14.1 (9.9)
WMS Verbal Paired Association 17.8 (5.0)
WMS Visual Paired Association 1 13.7 (4.3)
WMS Visual Paired Association 2 5.4 (1.3)
CPT Digit 2 3.5 (0.8)
CPT Digit 3 2.9 (0.9)
CPT Digit 4 2.0 (1.0)
WCST Categories Achieved 3.6 (1.9)
WCST Total Errors 19.7 (10.0)
AVLT Total 46.6 (14.3)
Category Fluency 16.3 (5.5)
Letter Fluency 22.0 (8.9)
ga −1.20 (0.98)
Functional skills UPSA-B Total 67.1 (17.8)
Social functioning SFS Social engagement/withdrawal 10.2 (2.3)
SFS Interpersonal behavior 6.6 (2.9)
SFS Pro-social activities 11.3 (7.8)
SFS Recreation 18.7 (6.2)
SFS Independence-competence 28.3 (7.4)
SFS Independence-performance 24.0 (7.9)
SFS Employment/occupation 5.5 (3.8)
SFS Total 104.6 (29.8)
Psychiatric symptoms PANSS Positive 18.4 (5.5)
PANSS Negative 19.9 (5.8)
PANSS General psychopathology 44.0 (11.3)
PANSS Total 82.3 (21.6)
Medication CPZeq (mg/day) 613.4 (577.4)
Subjective QOL SQLS Psychosocial 46.1 (23.0)
SQLS Motivation/energy 52.8 (22.7)
SQLS Symptoms/side effects 26.5 (18.1)
JART, Japanese Adult Reading Test; WAIS, Wechsler Adult Intelligence Scale-Third
Edition; WMS, Wechsler Memory Scale-Revised; CPT, Continuous Performance Test;
AVLT, Rey Auditory Verbal Learning Test; WCST, Wisconsin Card Sorting Test; UPSA-B,
Brief UCSD Performance-based Skills Assessment; SFS, Social Functioning Scale; PANSS,
Positive and Negative Syndrome Scale; CPZeq, chlorpromazine equivalent of total
antipsychotics; SQLS, Subjective Quality of Life Scale; and ANCOVA, analysis of
covariance (covariates: sex, age, years of education).
a The “g” composite was derived from the average of the z-scores (using control
means and standard deviations) of the cognitive measures.
Table 2






JART .418⁎⁎ .207⁎ .050
WAIS Similarities .534⁎⁎ .305⁎⁎ .227⁎
WAIS Digit Span .518⁎⁎ .184 .190
WAIS Arithmetic .649⁎⁎ .291⁎⁎ .329⁎⁎
WAIS Picture Completion .398⁎⁎ .393⁎⁎ .295⁎⁎
WAIS Digit Symbol Coding .496⁎⁎ .403⁎⁎ .392⁎⁎
WMS Logical Memory 1 .565⁎⁎ .326⁎⁎ .254⁎
WMS Logical Memory 2 .551⁎⁎ .325⁎⁎ .219⁎
WMS Verbal Paired Association .506⁎⁎ .352⁎⁎ .325⁎⁎
WMSVisual Paired Association 1 .470⁎⁎ .234⁎ .310⁎⁎
WMSVisual Paired Association 2 .358⁎⁎ .283⁎⁎ .187
CPT Digit 2 .478⁎⁎ .239⁎ .292⁎⁎
CPT Digit 3 .376⁎⁎ .187 .189
CPT Digit 4 .331⁎⁎ .138 .133
WCST Categories Achieved .453⁎⁎ .173 .252⁎
WCST Total Errors − .406⁎⁎ − .185 − .260⁎
AVLT Total .514⁎⁎ .304⁎⁎ .319⁎⁎
Category Fluency .389⁎⁎ .327⁎⁎ .275⁎⁎
Letter Fluency .456⁎⁎ .393⁎⁎ .276⁎⁎
ga .709⁎⁎ .423⁎⁎ .388⁎⁎
UPSA-B Total – .389⁎⁎ .486⁎⁎
PANSS Positive − .319⁎⁎ − .365⁎⁎ − .434⁎⁎
PANSS Negative − .431⁎⁎ − .546⁎⁎ − .517⁎⁎
PANSS General Psychopathology − .338⁎⁎ − .436⁎⁎ − .459⁎⁎
PANSS Total − .374⁎⁎ − .468⁎⁎ − .490⁎⁎
CPZeq (mg/day) − .269⁎ − .217⁎ − .255⁎
SQLS Psychosocial − .173 − .387⁎⁎ -.295⁎⁎
SQLS Motivation/Energy − .164 − .685⁎⁎ − .431⁎⁎
SQLS Symptoms/Side Effects − .339⁎⁎ − .325⁎⁎ − .281⁎⁎
Bold values indicate a signiﬁcant correlation (p b 0.05).
JART, Japanese Adult Reading Test; WAIS, Wechsler Adult Intelligence Scale-Third
Edition; WMS, Wechsler Memory Scale-Revised; CPT, Continuous Performance Test;
AVLT, Rey Auditory Verbal Learning Test; WCST, Wisconsin Card Sorting Test; UPSA-B,
Brief UCSD Performance-based Skills Assessment; SFS, Social Functioning Scale; PANSS,
Positive and Negative Syndrome Scale; CPZeq, chlorpromazine equivalent of total
antipsychotics; and SQLS, Subjective Quality of Life Scale.
a The “g” composite was derived from the average of the z-scores (using control
means and standard deviations) of the cognitive measures.
⁎ p b 0.05.
⁎⁎ p b 0.01 (2-tailed).
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capacity, as measured by the UPSA-B, may be important for the
employment/occupation domain of social functioning in patients with
schizophrenia, as poor cognitive abilities may underlie the deﬁcit
patients present in their ability to perform daily activities, which leads
to inefﬁciency in work life (Ho et al., 2013). These ﬁndings suggest an
important role of functional capacity as a link between cognitive
improvement and employment outcomes (Bowie and Harvey, 2006).
Consistent with previous studies (Bowie et al., 2006; Fujino et al.,
2014; Tas et al., 2013), negative symptoms were found to be
moderately associated with cognitive function, social functioning,
and QOL. Our model, which included a measure of subjective QOL,
indicated that part of QOL may be explained by real-world
functioning, which is consistent with previous results (Galuppi et
al., 2010). These ﬁndings suggest that better social functioning (e.g.,having a job), is associated with improved subjective QOL in patients
with schizophrenia, via increased motivation and energy.
The link between functional capacity and social functioning may
be affected by the degree of social support and other environmental
factors. While employment status, measured by the SFS, was
predicted by performance on the UPSA-B, other components of social
functioning (e.g., interpersonal communication and pro-social activ-
ities) were not. Enhancement of additional abilities, such as social
cognition and adaptive beliefs, may be required for the latter aspects
of social functioning to be improved (Addington et al., 2010; Green et
al., 2012). Moreover, social support, familial resources, ﬁnancial
disadvantage, and previous work history have been reported to affect
real-world functioning (Gould et al., 2012; Marwaha and Johnson,
2004). Inclusion of these factors may have increased the explanatory
power of our model.
Cognitive function was found to be more strongly associated with
functional capacity than with social functioning, consistent with
previous results (Durand et al., 2014; Green et al., 2004). By contrast,
cognitive performance was not correlated with social functioning in a
set of 106 demographically equivalent healthy control subjects (data
not shown), suggesting that patients' social functioning is more likely
to be affected by the level of cognitive function.
Some limitations of the current study should be considered. The
cross-sectional nature of this study does not allow us to draw
24 H. Fujino et al. / Schizophrenia Research: Cognition 3 (2016) 20–25conclusions concerning causal links among functional outcomes,
psychiatric symptoms, and QOL. Longitudinal studies are needed to
determine the consistency of the models presented here. Second, we
employed a self-report measure of QOL; a combination of self-reports
and interviewer ratings may have provided a more accurate
evaluation of QOL (Karow et al., 2012b). Third, although our model
accounted for signiﬁcant proportions of variance of employment
status, other factors, such as assistance from the clinical team as
would occur in assertive community treatment (Chandler et al., 1997;
Resnick et al., 2003), supported employment (Burns et al., 2007; Cook
et al., 2005), public assistance, and family support (Xiong et al., 1994),
might account for additional prediction of the variance. Inclusion of
these factors may have increased the explanatory power of our model.
In conclusion, the present study provides support for (1) the
concept that employment status and negative symptoms predict
subjective QOL, i.e., motivation and energy, and (2) the mediating role
of functional capacity in the ability of cognitive function to predict
employment status. Further research into the relationship between
cognitive function and social function may help to develop strategies
to alleviate the difﬁculties faced by patients with schizophrenia.
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